Teratoma Formation Assay for Assessing Pluripotency and Tumorigenicity of Pluripotent Stem Cells.
暂无分享,去创建一个
[1] H. Okano,et al. Fail-Safe System against Potential Tumorigenicity after Transplantation of iPSC Derivatives , 2017, Stem cell reports.
[2] Yoshimi Kawamura,et al. Tumour resistance in induced pluripotent stem cells derived from naked mole-rats , 2016, Nature Communications.
[3] Hideyuki Okano,et al. Steps Toward Safe Cell Therapy Using Induced Pluripotent Stem Cells , 2013, Circulation research.
[4] E. López-Bonet,et al. Metformin limits the tumourigenicity of iPS cells without affecting their pluripotency , 2012, Scientific Reports.
[5] Benjamin E. Reubinoff,et al. Standardization of the Teratoma Assay for Analysis of Pluripotency of Human ES Cells and Biosafety of Their Differentiated Progeny , 2012, PloS one.
[6] Hideyuki Okano,et al. Variation in the safety of induced pluripotent stem cell lines , 2009, Nature Biotechnology.
[7] T. Putti,et al. Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies. , 2009, Stem cell research.
[8] T. Ichisaka,et al. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.
[9] S. Yamanaka,et al. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.
[10] M. Kaufman,et al. Establishment in culture of pluripotential cells from mouse embryos , 1981, Nature.
[11] T. Ichisaka,et al. GENERATION OF GERMLINECOMPETENT INDUCED PLURIPOTENT STEM CELLS , 2007 .